Global Diosmin 90 Market to Reach USD 875 Million by 2032 Driven by Rising Demand in Cardiovascular and Phytopharmaceuti

التعليقات · 12 الآراء

The Diosmin 90 Market is experiencing robust growth, driven by increasing applications in cardiovascular health, venous insufficiency, and phytopharmaceutical formulations.

Market Overview

The Diosmin 90 Market is experiencing robust growth, driven by increasing applications in cardiovascular health, venous insufficiency, and phytopharmaceutical formulations. According to Market Intelo’s latest research, the global diosmin 90 market was valued at USD 520 million in 2024 and is projected to reach USD 875 million by 2032, growing at a CAGR of 6.2% during the forecast period.

Diosmin 90, a purified flavonoid derived from citrus fruits, is widely recognized for its therapeutic properties, including antioxidant, anti-inflammatory, and venotonic effects. Its applications in pharmaceuticals, nutraceuticals, and dietary supplements are expanding due to growing awareness of natural and plant-based therapies.

Key Market Drivers

Rising Prevalence of Cardiovascular and Venous Disorders

The increasing incidence of chronic venous insufficiency, hemorrhoids, and related cardiovascular conditions is driving the demand for diosmin 90-based treatments. Physicians and consumers are increasingly opting for natural and effective therapies over conventional medications.

Growing Nutraceutical and Dietary Supplement Industry

Diosmin 90 is widely used in nutraceutical formulations and dietary supplements for vascular health. The rising global health consciousness and preference for plant-based supplements are significantly fueling market growth.

Increasing Consumer Preference for Natural Products

Consumers are increasingly seeking natural, plant-derived, and safe therapeutic options. Diosmin 90’s origin from citrus flavonoids aligns with these preferences, driving adoption in pharmaceutical, nutraceutical, and functional food applications.

Pharmaceutical and Therapeutic Applications

Diosmin 90 is a critical component in formulations for vascular protection, anti-inflammatory therapy, and antioxidant supplements. Its proven efficacy and regulatory acceptance for clinical use further support market expansion.

Market Segmentation

By Form

  • Powdered Form – Commonly used in pharmaceutical and nutraceutical formulations.

  • Capsules & Tablets – Direct application in dietary supplements and therapeutic products.

  • Liquid & Extract Form – Used in specialized nutraceutical and functional food products.

By Application

  • Pharmaceuticals – Venoactive drugs, anti-inflammatory therapies, and cardiovascular supplements.

  • Nutraceuticals & Dietary Supplements – Capsules, tablets, and functional foods promoting vascular health.

  • Cosmetics & Personal Care – Incorporated in anti-aging and antioxidant skincare formulations.

  • Others – Research, clinical studies, and experimental therapeutics.

By End-User

  • Hospitals & Clinics – Diosmin 90-based therapeutic treatments for chronic venous disorders.

  • Pharmacies & Drug Stores – Over-the-counter nutraceutical and dietary supplement products.

  • Online Retail & E-Commerce – Growing availability of plant-based flavonoid supplements to end consumers.

Regional Insights

North America

North America holds a significant share of the diosmin 90 market, fueled by high awareness of vascular health, advanced healthcare infrastructure, and the popularity of natural supplements. The U.S. dominates the region with strong adoption in both nutraceuticals and pharmaceuticals.

Europe

Europe is a major market for diosmin 90, particularly in countries like Germany, France, and Italy, where demand for natural therapies and dietary supplements is high. Regulatory support for plant-based products further strengthens the market.

Asia-Pacific

Asia-Pacific is projected to record the fastest growth during the forecast period. Rising prevalence of lifestyle-related cardiovascular disorders, increasing disposable incomes, and growing awareness of nutraceuticals in India, China, and Japan are key drivers.

Latin America and Middle East & Africa

These regions are emerging markets for diosmin 90, supported by increasing healthcare spending, rising chronic disease prevalence, and growing adoption of herbal and plant-based supplements. Brazil, South Africa, and UAE are significant contributors to regional growth.

Competitive Landscape

The global diosmin 90 market is moderately competitive, with key players focusing on product innovation, quality enhancement, and strategic partnerships. Companies are investing in research and development to offer high-purity diosmin 90 and expand applications in pharmaceuticals and nutraceuticals.

Leading companies operating in the market include:

  • Hunan Zhongxin Pharmaceutical Co., Ltd.

  • Alkem Laboratories Limited

  • Micronized Diosmin Manufacturers

  • Diosmin Flavonoid Suppliers (India and China)

  • Indena S.p.A.

  • Herba Ingredients Inc.

  • Kancor Ingredients Limited

  • Jiangsu Yongle Medicine Co., Ltd.

These companies are strengthening global distribution, expanding production capacity, and entering new partnerships to enhance their market presence in key regions.

Market Trends

  • Rising Focus on Natural Therapeutics: Increasing preference for plant-derived active ingredients in pharmaceutical and nutraceutical formulations.

  • Functional Foods and Supplements: Incorporation of diosmin 90 in dietary supplements to support cardiovascular and vascular health.

  • E-commerce and Online Distribution: Growing online sales of flavonoid-based supplements enhance market accessibility.

  • Sustainable Extraction and Purification: Emphasis on eco-friendly extraction processes and high-purity diosmin 90 production to meet quality standards.

Future Outlook

The global diosmin 90 market is expected to sustain steady growth through 2032, driven by increasing prevalence of cardiovascular and venous disorders, rising health consciousness, and growing demand for plant-based therapeutics. Pharmaceuticals and nutraceuticals will remain dominant segments, while cosmetic applications and research-oriented uses offer additional opportunities.

Companies prioritizing high-quality products, regulatory compliance, and sustainable production are expected to lead the market, while ongoing innovation in formulations and global expansion strategies will further strengthen market potential.


Read Full Research Study: https://marketintelo.com/report/diosmin-90-market


About Market Intelo

MarketIntelo is a trusted market research and consulting firm, dedicated to delivering actionable insights across diverse industries. We specialize in offering comprehensive market intelligence reports that enable businesses to make strategic and well-informed decisions. Backed by a robust database of market information and a skilled team of analysts, MarketIntelo provides tailored solutions designed to meet the evolving needs of our clients.

التعليقات